Vaccination may be key to reducing effects of long Covid

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
loading...
Loading, please wait...
0:00
play article
Subscribers can listen to this article
vaccination
vaccination

Covid-19 vaccines have been shown to reduce the risk of severe disease and death. A new study has found that taking at least one dose of AstraZeneca, Pfizer, or Moderna Covid vaccines could help reduce long Covid symptoms.

The study published in The BMJ investigated the link between Covid-19 vaccination and long Covid symptoms in adults infected with SARS-CoV-2 before vaccination.

The researchers enrolled 28 356 UK participants aged between 18 and 69 years who received at least one dose of an adenovirus vector or mRNA Covid-19 vaccine after testing positive for Covid-19 infection.

Read this for free
Get 14 days free to read all our investigative and in-depth journalism. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed.
Subscribe
Already a subscriber? Sign in
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
27% - 9955 votes
No
73% - 26319 votes
Vote